Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

EKF Lead Collaborator in Biomarkers of Progressive Diabetic Kidney Disease to Deliver Prestigious Kelly West Lecture at ADA Scientific Sessions for 2014

publication date: Jun 20, 2014
 | 
author/source: EKF Diagnostics

EKF Diagnostics, the global diagnostics company, today highlights that the lead scientist working in collaboration with its Kidney Biomarker team to develop tests for progressive Diabetic Kidney Disease (DKD) will receive the 2014 Kelly West Award in Epidemiology at the American Diabetes Association (ADA) 74th Scientific Sessions.

EKF logo.Dr. Andrzej Krolewski, MD, PhD, Head of Section on Genetics and Epidemiology at the Joslin Diabetes Center and Professor of Medicine at Harvard Medical School, receives this eminent award in recognition of his significant contribution to the field of diabetes epidemiology.

At the ADA 74th Scientific Sessions (13-17th June, 2014, San Francisco), Dr. Krolewski will also deliver the Kelly West Award lecture, ‘Time to Retire ‘Microalbuminuria’: Early, Progressive Renal Decline is the New Paradigm,’ (15th June, 2.15pm). “I am very pleased that I was selected to give the Kelly West Lecture,” said Dr. Krolewski. “This lecture will give me the opportunity to discuss important discoveries that we made in regard to diabetic kidney disease. Joslin is one of the best places to conduct this type of epidemiological research.”

Julian Baines, CEO, EKF Diagnostics, commented, “We offer our wholehearted congratulations to Dr. Andrzej Krolewski on his receipt of the Kelly West Award which is one of the ADA’s highest scientific awards. We look forward to continuing our partnership with him and his team as they continue to develop new models for management of Diabetic Kidney Disease and in particular, the role of biomarkers such as sTNFR1.”

On Stand 2321 at the ADA 74th Science Sessions, EKF Diagnostics will be exhibiting the first of its diagnostics tests for progressive DKD based on the sTNFR1 biomarker originally identified by Dr. Krolewski as a strong predictor of ESRD. Studies performed in multiple centers in US and Europe have shown that sTNFR1 outperforms current clinical tests in identifying high risk patients. EKF’s sTNFR1 test kit is an easy-to-use ELISA-based assay for which standard laboratory equipment and just 50 µL of blood serum or plasma are needed. The standard assay format means the test requires minimal training.


more about EKF diagnostics


 

 


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners